References
- Aye M M, Matsuoka E, et al. Histopathological analysis of four autopsy cases of HTLV-1-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol (Berl) 2000; 100: 245–252, [CSA]
- Bagnato F, Butman J A, et al. Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. J NeuroVirol 2005; 11: 525–534, [INFOTRIEVE], [CSA], [CROSSREF]
- Cruickshank J K, Rudge P, et al. Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain 1989; 112: 1057–1090, [INFOTRIEVE], [CSA]
- Fukushima T, Ikeda T, et al. Cognitive event-related potentials and brain magnetic resonance imaging in HTLV-1 associated myelopathy (HAM). J Neurol Sci 1994; 126: 30–39, [INFOTRIEVE], [CSA], [CROSSREF]
- Godoy A J, Kira J, et al. Characterization of cerebral white matter lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen-vasculitis: a semiquantitative MRI study. J Neurol Sci 1995; 133: 102–111, [INFOTRIEVE], [CSA], [CROSSREF]
- Howard A K, Li D K, et al. MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives. Can J Neurol Sci 2003; 30: 41–48, [INFOTRIEVE], [CSA]
- Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002; 186(Suppl 2)S187–S192, [INFOTRIEVE], [CSA], [CROSSREF]
- Kannagi M, Ohashi T, et al. Immunological risks of adult T-cell leukemia at primary HTLV-I infection. Trends Microbiol 2004; 12: 346–352, [INFOTRIEVE], [CSA], [CROSSREF]
- Kasahata N, Shiota J, et al. Acute human T-lymphotropic virus type 1-associated myelopathy: a clinicopathologic study. Arch Neurol 2003; 60: 873–876, [INFOTRIEVE], [CSA], [CROSSREF]
- Kurtzke J F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452, [INFOTRIEVE], [CSA]
- Melo A, Moura L, et al. Magnetic resonance imaging in HTLV-I associated myelopathy. Arq Neuropsiquiatr 1993; 51: 329–332, [INFOTRIEVE], [CSA]
- Miller D H, Barkhof F, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002; 125: 1676–1695, [INFOTRIEVE], [CSA], [CROSSREF]
- Osame M. Review of WHO Kagoshima Meeting and Diagnostic guidelines for HAM/TSP. Human Retrovirology HTLV, 1st ed., W A Blattner. Raven Press, New York 1990; 191–197
- Pelletier D, Garrison K, et al. Measurement of whole-brain atrophy in multiple sclerosis. J Neuroimaging 2004; 14: 11S–19S, [INFOTRIEVE], [CSA], [CROSSREF]
- Pham D L, Xu C, et al. Current methods in medical image segmentation. Annu Rev Biomed Eng. 2000; 2: 315–337, [INFOTRIEVE], [CSA], [CROSSREF]
- Rudick R A, Fisher E, et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999; 53: 1698–1704, [INFOTRIEVE], [CSA]
- Rusinek H, Endo Y, et al. Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology 2004; 63: 2354–2359, [INFOTRIEVE], [CSA]
- Shattuck D W, Sandor-Leahy S R, et al. Magnetic resonance image tissue classification using a partial volume model. NeuroImage 2001; 13: 856–876, [INFOTRIEVE], [CSA], [CROSSREF]
- Smith S M, De Stefano N, et al. Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 2001; 25: 466–475, [INFOTRIEVE], [CSA], [CROSSREF]
- Smith S M, Zhang Y, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479–489, [INFOTRIEVE], [CSA], [CROSSREF]
- Takenouchi N, Yao K, et al. Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches. Front Biosci 2004; 9: 2527–2539, [INFOTRIEVE], [CSA]
- Yamano Y, Nagai M, et al. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002; 99: 88–94, [INFOTRIEVE], [CSA], [CROSSREF]